PDS Biotechnology Earnings Conference Call Is Coming Up, Here’s What You Need To Know
PDS Biotechnology (NASDAQ:PDSB) will host a conference call at 08:00 AM ET on March 31, 2022, to discuss Q4 2021 earnings results.
Earnings Scheduled For March 23, 2022
Companies Reporting Before The Bell
• AYRO (NASDAQ:AYRO) is expected to report earnings for its fourth quarter.
Earnings Preview For PDS Biotechnology
PDS Biotechnology (NASDAQ:PDSB) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement.
Analysts estimate that PDS Biotechnology will report an earnings per share (EPS) of $-0.24.
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment during the week.
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
PDS Biotech Reports Prelim. Efficacy Achievement In VERSATILE-002 Phase 2 Trial Of PDS0101 In Combo With KEYTRUDA In Advanced Head And Neck Cancer
Achievement of initial efficacy milestone allows full enrollment of checkpoint inhibitor naïve cohort
FLORHAM PARK, N.J., Feb. 02, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB), a
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours.
PDS Biotechnology Q3 EPS $(0.24) Misses $(0.20) Estimate
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.20) by 20 percent. This is a 4.35 percent decrease over losses of $(0.23) per share from
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.